copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
A Practical Review of Long-Acting Injectable Antipsychotics ABSTRACT: Long-acting injectable (LAI) antipsychotics are an important treatment option to help improve adherence in patients with schizophrenia and schizoaffective disorder LAI antipsychotics are managed and dosed differently than oral antipsychotics
Psychiatric Pharmacy Essentials: Long-acting Injectable Antipsychotics They offer several benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability, and prevention of antipsychotic overdose LAIs are commonly used with the notion that they will decrease relapse rates by improving medication adherence; however, the data is limited
Atypical Antipsychotic Long-Acting Injectable (LAI) Review . . . There are three aripiprazole LAI dosage forms, with similar indications and routes of administration None require refrigeration but all require oral overlap for 14-21 days and must be shaken prior to administration
Long-Acting Injectable Antipsychotics (LAIs) - PsychDB Long-Acting Injectable (LAI) Antipsychotics are antipsychotics delivered via intramuscular injection that can provide medication coverage from a period of weeks to months Once stabilized on an LAI, patients rarely will need oral antipsychotic supplementation
A Comprehensive Guide to Long-Acting Injectable Antipsychotics for . . . We propose a paper that provides education on commonly used long-acting injectable antipsychotics (LAIs) to improve primary care based mental health interventions in patients with severe mental illnesses (SMIs) such as schizophrenia, schizoaffective disorder, and bipolar disorders
Long-Acting Injectable (LAI) Medication - Provider Express When treating schizophrenia, the medication assessment should include the use of the long-acting injectable (LAI) formulations of antipsychotic medication; consideration should include patient age, preferences and or a history of poor or uncertain adherence (source: American Psychiatric Association)